Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain

被引:48
作者
Ahlawat, Abhilasha [1 ]
Rana, Ajay [1 ]
Goyal, Nidhi [1 ]
Sharma, Saurabh [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmacol, Moga, India
关键词
Nitric oxide synthase; Diabetic neuropathy; Peroxynitrite; NMDA; Neuronal hyperexcitability; C-FOS EXPRESSION; PERIPHERAL NEUROPATHY; REACTIVE OXYGEN; CUNEATE NUCLEUS; PHOSPHORYLATION; STIMULATION; GENE; DEGENERATION; GANGLION; RELEASE;
D O I
10.1007/s10787-014-0213-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Neuropathic pain triggers a cascade of events in the sensory neurons. It is the main complication of diabetes after cardiovascular disease. Nitric oxide (NO) produced from nitric oxide synthases (NOS) is an important signaling molecule which is crucial for many physiological processes such as synaptic plasticity, neuronal survival, vasodilation, vascular homeostasis, immune regulation. Overproduction of NO due to changes in NOS isoforms level involves pathological processes such as neurotoxicity, septic shock and neuropathic pain. All three isoforms of NOS as well as their end product, NO have modulatory effect on neuropathic pain. Overactivation of the N-Methyl-d-Aspartate receptor and peroxynitrite formation results in high levels of neuronal NOS (nNOS) and endothelial NOS (eNOS) which suggest that nNOS and eNOS are critical for pain hypersensitivity. Inducible NOS induced in glia by inflammation due to activation of Tumor Necrosis Factor alpha, Calcitonin Gene Regulating Peptide, Mitogen Activated Protein Kinases, Extracellular signal Regulated Kinase, c-Jun N-terminal kinases can induce neuronal death. This review focuses on different nitric oxide synthases and their role in pathophysiology of neuropathic pain considering NOS as an important therapeutic target.
引用
收藏
页码:269 / 278
页数:10
相关论文
共 80 条
[1]
Acute energy restriction triggers Wallerian degeneration in mouse [J].
Alvarez, Susana ;
Moldovan, Mihai ;
Krarup, Christian .
EXPERIMENTAL NEUROLOGY, 2008, 212 (01) :166-178
[2]
Antosova M, 2012, OPEN J MOL INTEGR PH, V2, P9
[3]
Baron R, 2000, ANAESTHESIST, V49, P373, DOI 10.1007/s001010070105
[4]
Endothelial Nitric Oxide Synthase in Dorsal Root Ganglia during Chronic Inflammatory Nociception [J].
Borsani, Elisa ;
Giovannozzi, Sara ;
Cocchi, Marco Angelo ;
Boninsegna, Ramon ;
Rezzani, Rita ;
Rodella, Luigi F. .
CELLS TISSUES ORGANS, 2013, 197 (02) :159-168
[5]
Boulton Andrew J M, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P141, DOI 10.1097/MED.0b013e328014979e
[6]
Nitric oxide and neuronal death [J].
Brown, Guy C. .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2010, 23 (03) :153-165
[7]
Purinergic P2 receptors as targets for novel analgesics [J].
Burnstock, Geoffrey .
PHARMACOLOGY & THERAPEUTICS, 2006, 110 (03) :433-454
[8]
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity [J].
Calabrese, Vittorio ;
Mancuso, Cesare ;
Calvani, Menotti ;
Rizzarelli, Enrico ;
Butterfield, D. Allan ;
Stella, Anna Maria Giuffrida .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (10) :766-775
[9]
Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO
[10]
2-K